Ignite Creation Date:
2024-05-05 @ 4:38 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00288067
Status:
TERMINATED
Last Update Posted:
2014-10-06
First Post:
2006-02-06
Brief Title:
Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma |
| B-cell Chronic Lymphocytic Leukemia |
| Contiguous Stage II Adult Burkitt Lymphoma |
| Contiguous Stage II Adult Diffuse Large Cell Lymphoma |
| Contiguous Stage II Adult Lymphoblastic Lymphoma |
| Contiguous Stage II Grade 1 Follicular Lymphoma |
| Contiguous Stage II Grade 2 Follicular Lymphoma |
| Contiguous Stage II Mantle Cell Lymphoma |
| Stage II Marginal Zone Lymphoma |
| Stage II Small Lymphocytic Lymphoma |
| Extranodal Marginal Zone B-cell Lymphoma |
| Nodal Marginal Zone B-cell Lymphoma |
| Noncontiguous Stage II Adult Burkitt Lymphoma |
| Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma |
| Noncontiguous Stage II Adult Lymphoblastic Lymphoma |
| Noncontiguous Stage II Grade 1 Follicular Lymphoma |
| Noncontiguous Stage II Grade 2 Follicular Lymphoma |
| Noncontiguous Stage II Mantle Cell Lymphoma |
| Recurrent Adult Burkitt Lymphoma |
| Recurrent Adult Diffuse Large Cell Lymphoma |
| Recurrent Adult Hodgkin Lymphoma |
| Recurrent Adult Lymphoblastic Lymphoma |
| Recurrent Grade 1 Follicular Lymphoma |
| Recurrent Grade 2 Follicular Lymphoma |
| Recurrent Mantle Cell Lymphoma |
| Recurrent Marginal Zone Lymphoma |
| Recurrent Small Lymphocytic Lymphoma |
| Refractory Chronic Lymphocytic Leukemia |
| Splenic Marginal Zone Lymphoma |
| Stage I Adult Burkitt Lymphoma |
| Stage I Adult Diffuse Large Cell Lymphoma |
| Stage I Adult Hodgkin Lymphoma |
| Stage I Adult Lymphoblastic Lymphoma |
| Stage I Chronic Lymphocytic Leukemia |
| Stage I Grade 1 Follicular Lymphoma |
| Stage I Grade 2 Follicular Lymphoma |
| Stage I Small Lymphocytic Lymphoma |
| Stage II Adult Hodgkin Lymphoma |
| Stage II Chronic Lymphocytic Leukemia |
| Stage III Adult Burkitt Lymphoma |
| Stage III Adult Diffuse Large Cell Lymphoma |
| Stage III Adult Hodgkin Lymphoma |
| Stage III Adult Lymphoblastic Lymphoma |
| Stage III Chronic Lymphocytic Leukemia |
| Stage III Grade 1 Follicular Lymphoma |
| Stage III Grade 2 Follicular Lymphoma |
| Stage III Mantle Cell Lymphoma |
| Stage III Marginal Zone Lymphoma |
| Stage III Small Lymphocytic Lymphoma |
| Stage IV Adult Burkitt Lymphoma |
| Stage IV Adult Diffuse Large Cell Lymphoma |
| Stage IV Adult Hodgkin Lymphoma |
| Stage IV Adult Lymphoblastic Lymphoma |
| Stage IV Chronic Lymphocytic Leukemia |
| Stage IV Grade 1 Follicular Lymphoma |
| Stage IV Grade 2 Follicular Lymphoma |
| Stage IV Mantle Cell Lymphoma |
| Stage IV Marginal Zone Lymphoma |
| Stage IV Small Lymphocytic Lymphoma |
| Waldenström Macroglobulinemia |
Keywords: